Market View 18th December 2023

View on market: Volatility Prevails, Market is searching for better value

Prior to the warning about the outcome of the Bank of Japan’s policy meeting and the economic data from China, the majority of Asian markets saw a decrease on Monday. Hong Kong markets saw an increase, whereas share indices in South Korea, Japan, and the Chinese mainland saw declines. Around $77.08 per barrel, Brent crude was up 0.69% on the market. An ounce of gold was trading at $2,022.48, up 0.14%. As of 06:58 a.m., the GIFT Nifty was trading 0.12% higher at 21,481.

Economic Calendar:

• USD : Building Permits (Nov) on 19th December, 2023
• USD : Existing Home Sales (Nov) on 20th December, 2023
• INR : FX Reserves, USD on 22nd December, 2023
• INR : RBI MPC Meeting Minutes on 22nd December, 2023

Brokerage Radar:

UBS ON DIXON TECH: Initiate Buy, Target Rs 7,700; Co Well Diversified With Large Opportunity In Mobile And IT Hardware; Co Trades At 63x FY25 PE; Believe The Higher Valuation Is Justified By Strong 41% Earnings CAGR In FY24-26; Execution Is a Key Risk

MS ON BHARTI AIRTEL: Are already assuming an ARPU increase of >20% cumulatively over next 24-30 months, which think is well reflected in current stock price.

International Markets

U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency:

FIIs & DIIs:

News Update:

Zee Entertainment Enterprises: The company has requested Culver Max Entertainment Pvt. Ltd. — formerly known as Sony Pictures Networks India Pvt. Ltd. — and Bangla Entertainment Pvt. Ltd. to extend the timeline required to make their merger effective.

Mankind Pharma: The company acquired an additional 1.3% stake in Actimed Therapeutics for about £999,900. The company’s stake rises to 10.19%.

NBCC: The company conducted an auction for the sale of 2.23 lakh square feet in the World Trade Centre and sold commercial inventory worth Rs 905 crore. Total sales of commercial inventory through e-auction stand at Rs 9,656.6 crore.

Tata Power: The company signed Rs 418 crore pacts for supplying 152 MWp DCR solar PV modules to NTPC.

Lupin: The pharma major received approval from the United States Food and Drug Administration for its abbreviated new drug application for Allopurinol Tablets USP and Sitagliptin Tablets USP.

Indian Bank: The company raises Rs 4,000 crore by issuing 10.15 crore shares via QIP at Rs 394 per share, which indicates a discount of 4.9% to the floor price of Rs 414.44 per share.

Mahindra & Mahindra: The company’s unit incorporated a wholly owned subsidiary named Migos Hybren Pvt. for power and electricity generation.

Adani Green: The company unit incorporated two wholly owned subsidiaries, namely, Adani Renewable Energy Fifty Eight and Adani Renewable Energy Sixty One.

Sumitomo Chemical: The company acquired an 85% stake in Barrix Agro Sciences for Rs 78.2 crore.

Landmark Cars: The company has received a letter of intent from MG Motor India for opening a dealership in Ahmedabad, Gujarat. This dealership will be established by Aeromark Cars Private Ltd., a wholly owned subsidiary company of Landmark Cars.

TTK Healthcare: The company re-commenced production activities on Friday.

MSTC: The government appointed Manobendra Ghoshal as chairman and managing director.

Mazagon Dock Shipbuilders: The company signed individual shipbuilding contracts with the European client for the construction of three units of 7,500 DWT multi-purpose hybrid-powered vessels for $42 million.

Macrotech Developers: The company disposes of equity and investments in entities in the U.K.

Kokuyo Camlin: The company approved the acquisition of land and a building adjacent to the company’s existing factory at Samba, Jammu for Rs 4.60 crore.

United Spirits: The company gets a claim worth Rs 365.33 crore from an institutional customer in relation to a previously concluded settlement with the customer. The company cannot determine the financial implications of this claim.

Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.